An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus
NCT03252587
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
363
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
BMS-986165
OTHER:
Placebo
Sponsor
Bristol-Myers Squibb